Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

The activation of adenosine monophosphate-activated protein kinase in rat hippocampus contributes to the rapid antidepressant effect of ketamine.

Xu SX, Zhou ZQ, Li XM, Ji MH, Zhang GF, Yang JJ.

Behav Brain Res. 2013 Sep 15;253:305-9. doi: 10.1016/j.bbr.2013.07.032. Epub 2013 Jul 29.

PMID:
23906767
2.

Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.

Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ.

Eur Psychiatry. 2014 Sep;29(7):419-23. doi: 10.1016/j.eurpsy.2013.10.005. Epub 2013 Dec 8.

PMID:
24321772
3.

Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test.

Wang X, Yang Y, Zhou X, Wu J, Li J, Jiang X, Qu Q, Ou C, Liu L, Zhou S.

Psychiatry Res. 2011 Jan 30;185(1-2):248-53. doi: 10.1016/j.psychres.2010.04.046. Epub 2010 May 23.

PMID:
20580983
4.

Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test.

Yang C, Hu YM, Zhou ZQ, Zhang GF, Yang JJ.

Ups J Med Sci. 2013 Mar;118(1):3-8. doi: 10.3109/03009734.2012.724118. Epub 2012 Sep 13.

5.

Tramadol reinforces antidepressant effects of ketamine with increased levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in rat hippocampus.

Yang C, Li X, Wang N, Xu S, Yang J, Zhou Z.

Front Med. 2012 Dec;6(4):411-5. doi: 10.1007/s11684-012-0226-2. Epub 2012 Nov 3.

PMID:
23124884
6.

Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.

Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J.

Behav Brain Res. 2011 Aug 1;221(1):166-71. doi: 10.1016/j.bbr.2011.02.024. Epub 2011 Mar 21.

PMID:
21397634
7.

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus.

Garcia LS, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, Andreazza AC, Stertz L, Fries GR, Gavioli EC, Kapczinski F, Quevedo J.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):140-4. Epub 2007 Aug 8.

PMID:
17884272
8.

Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.

Garcia LS, Comim CM, Valvassori SS, Réus GZ, Andreazza AC, Stertz L, Fries GR, Gavioli EC, Kapczinski F, Quevedo J.

Basic Clin Pharmacol Toxicol. 2008 Dec;103(6):502-6. doi: 10.1111/j.1742-7843.2008.00210.x.

9.

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.

Lindholm JS, Autio H, Vesa L, Antila H, Lindemann L, Hoener MC, Skolnick P, Rantamäki T, Castrén E.

Neuropharmacology. 2012 Jan;62(1):391-7. doi: 10.1016/j.neuropharm.2011.08.015. Epub 2011 Aug 16.

PMID:
21867718
10.

Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.

Suwa M, Nakano H, Radak Z, Kumagai S.

Metabolism. 2011 Mar;60(3):394-403. doi: 10.1016/j.metabol.2010.03.003. Epub 2010 Apr 1.

PMID:
20362304
11.

Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.

Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, Han M, Hashimoto K.

Psychopharmacology (Berl). 2015 Dec;232(23):4325-35. doi: 10.1007/s00213-015-4062-3. Epub 2015 Sep 4.

PMID:
26337614
12.

Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.

Li HL, Yin R, Chen D, Liu D, Wang D, Yang Q, Dong YG.

J Cell Biochem. 2007 Apr 1;100(5):1086-99.

PMID:
17266062
13.

Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR.

Akinfiresoye L, Tizabi Y.

Psychopharmacology (Berl). 2013 Nov;230(2):291-8. doi: 10.1007/s00213-013-3153-2. Epub 2013 Jun 4.

14.

MAPK signaling correlates with the antidepressant effects of ketamine.

Réus GZ, Vieira FG, Abelaira HM, Michels M, Tomaz DB, dos Santos MA, Carlessi AS, Neotti MV, Matias BI, Luz JR, Dal-Pizzol F, Quevedo J.

J Psychiatr Res. 2014 Aug;55:15-21. doi: 10.1016/j.jpsychires.2014.04.010. Epub 2014 Apr 18.

PMID:
24819632
15.

Tramadol pretreatment enhances ketamine-induced antidepressant effects and increases mammalian target of rapamycin in rat hippocampus and prefrontal cortex.

Yang C, Li WY, Yu HY, Gao ZQ, Liu XL, Zhou ZQ, Yang JJ.

J Biomed Biotechnol. 2012;2012:175619. doi: 10.1155/2012/175619. Epub 2012 Apr 8.

16.

Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine.

Wang N, Zhang GF, Liu XY, Sun HL, Wang XM, Qiu LL, Yang C, Yang JJ.

J Mol Neurosci. 2014;54(2):211-8. doi: 10.1007/s12031-014-0277-8. Epub 2014 Mar 16.

PMID:
24633675
17.

Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.

Gideons ES, Kavalali ET, Monteggia LM.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8649-54. doi: 10.1073/pnas.1323920111. Epub 2014 May 27.

18.

Akt mediates GSK-3β phosphorylation in the rat prefrontal cortex during the process of ketamine exerting rapid antidepressant actions.

Zhou W, Dong L, Wang N, Shi JY, Yang JJ, Zuo ZY, Zhou ZQ.

Neuroimmunomodulation. 2014;21(4):183-8. doi: 10.1159/000356517. Epub 2014 Feb 6.

PMID:
24504086
19.

Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.

Jett JD, Boley AM, Girotti M, Shah A, Lodge DJ, Morilak DA.

Psychopharmacology (Berl). 2015 Sep;232(17):3123-33. doi: 10.1007/s00213-015-3957-3. Epub 2015 May 20.

PMID:
25986748
20.

AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus.

Gadalla AE, Pearson T, Currie AJ, Dale N, Hawley SA, Sheehan M, Hirst W, Michel AD, Randall A, Hardie DG, Frenguelli BG.

J Neurochem. 2004 Mar;88(5):1272-82.

Items per page

Supplemental Content

Write to the Help Desk